Deciphering the Molecular Events Necessary for Synergistic Tumor Cell Apoptosis Mediated by the Histone Deacetylase Inhibitor Vorinostat and the BH3 Mimetic ABT-737
Adrian P Wiegmans, Amber E Alsop, Michael Bots, Leonie A Cluse, Steven P Williams, Kellie-Marie Banks, Rachael Ralli, Clare L Scott, Anna Frenzel, Andreas Villunger, Ricky W Johnstone
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2011
Awarded by AICR
R.W. Johnstone is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and supported by NHMRC Program and Project Grants, the Susan G. Komen Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, Cancer Council Victoria, Victorian Breast Cancer Research Consortium, and the Australian Rotary Health Foundation. A. Villunger is supported by the AICR (grant no. 06-440) and the Austrian Science Fund (FWF). R.W. Johnstone received a collaborative research grant from Merck and Co. for research involving vorinostat.